『2 Minutes with Joey - MDT Stock News』のカバーアート

2 Minutes with Joey - MDT Stock News

2 Minutes with Joey - MDT Stock News

著者: 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Medtronic (MDT) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • MDT Today - Aug 13: Slight Gain Amidst Competition
    2026/08/13
    Hey there! I’m Joey, a longtime investor here to break down the day for you. Today we’re talking about Medtronic, and it was a pretty chill day, moving up just a smidge, like 0.5%.

    So, what went down? Medtronic had a decent day, barely moving but still in the green. It seems like folks were feeling okay about it, but nothing too wild. It was a slow bleed earlier in the day, but by the time the closing bell rang, it managed to inch upwards.

    Now, why the slight bump? Well, it looks like some analysts are keeping an eye on Medtronic and think it’s still got some potential. They’re revisiting it alongside other stocks, which is always a good sign. Plus, it outperformed some competitors today, which definitely helped. People are still trying to figure out if it’s a bargain, especially after some recent wins with CE marking. But let’s be real—there's a lot of chatter about competitors, particularly Intuitive, making waves and crowding out some of Medtronic's market space. That’s gotta sting a little, right?

    On the horizon, there’s buzz about how Western Wealth Management has a notable position in Medtronic. It’s always interesting to see big players making moves in a stock. That could mean they see something we don’t, or they’re just riding the wave.

    So, to wrap it up, Medtronic had a quiet day, but a little gain is still a gain! Keep an eye on those competitors, though. Remember, this is just for info and fun—no financial advice here. Catch you later!
    続きを読む 一部表示
    1 分
  • MDT Today - Aug 12: CE Mark Win Sparks Interest
    2026/08/12
    Hey, what’s up? It’s Joey here, your friendly longtime investor, breaking down the day. So, let’s talk about Medtronic, or MDT for short. Today was a bit of a red day—down about 1.2%. Ouch.

    So, what went down? The stock hit a little bump after a recent CE mark win, which usually would be good news. But today, it kinda got smoked. It opened strong but then just faded away. Volume was pretty steady, so it wasn’t like people were panicking or anything; it just seemed like a slow bleed.

    Now, why the drop? Well, folks are still trying to figure out if Medtronic really trades at a discount after that CE mark win. Some analysts are saying it’s a good time to buy, while others aren’t so sure. Plus, UBS upgraded the stock recently, saying there’s strong growth in their cardiac division. You’d think that would get people excited, but it seems like investors are a bit cautious. Maybe they’re waiting to see if that growth actually translates into solid numbers.

    Oh, and here’s a quick thing worth knowing: Cardinal Capital just upped their stake in Medtronic. That’s usually a sign someone’s feeling optimistic, even if the stock isn’t showing it right now.

    So, yeah, a bit of a mixed bag today for MDT. It’s like when you’re waiting for your favorite show to drop a new season, and it turns out to be a little disappointing. But, hey, that’s just how the market rolls sometimes. Just remember, this is all for your info and entertainment. I’m not giving any buy or sell advice here. Catch you later!
    続きを読む 一部表示
    1 分
  • MDT Today - Aug 11: Trust Cuts Position
    2026/08/11
    Hey there! It’s Joey here, your friendly longtime investor breaking down the day. Today, we’re talking about Medtronic, and guess what? It was a green day! The stock was up about 1.1%.

    So, what went down? Medtronic had a pretty solid trading day overall. It outperformed some competitors, which is always nice to see. But it wasn’t all sunshine. There was some chatter about Perkins Coie Trust cutting its stock position in Medtronic. Yeah, that one stung a bit for investors.

    Now, why did all this happen? Well, some analysts are still keeping a neutral rating on Medtronic, especially when it comes to their renal coverage. It's a bit of a mixed bag. On one hand, it's good to see Medtronic holding its ground against others in the healthcare space. On the other hand, with that trust cutting their position, it might have made some investors a little jittery.

    Also, there’s been some buzz comparing Medtronic to Johnson & Johnson after their earnings reports. Analysts are trying to figure out which stock is better positioned, and that’s always a hot topic.

    One quick thing to keep in mind: Medtronic continues to be spotlighted by some of Wall Street's most accurate analysts, who think it’s among the healthcare stocks delivering solid dividend yields. So, while today had its ups and downs, there’s still some positive chatter out there.

    That’s a wrap for today! Just remember, I’m here to keep you in the loop, not to give any financial advice. Catch you later!
    続きを読む 一部表示
    1 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません